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Impaired Keratinocyte Proliferative and Clonogenic
Potential in Transgenic Mice Overexpressing
14-3-3r in the Epidermis
Francesca Cianfarani1, Silvia Bernardini1, Naomi De Luca1, Elena Dellambra2, Laura Tatangelo3,5,
Cecilia Tiveron3,6, Carien M. Niessen4, Giovanna Zambruno1, Daniele Castiglia1,7 and Teresa Odorisio1,7
The 14-3-3 protein family controls diverse biochemical processes through interaction with phosphorylated
consensus sequences in protein targets. Its epithelial specific member, 14-3-3s, also known as stratifin, is highly
expressed in differentiated keratinocytes, and in vitro evidence indicates that 14-3-3s downregulation leads to
keratinocyte immortalization. To define the role of 14-3-3s in skin homeostasis in vivo, we generated transgenic
mice overexpressing 14-3-3s in proliferating keratinocytes of the epidermis and hair follicle. Transgenic animals
show decreased epidermal thickness and hair follicle density associated with reduced number of proliferating
keratinocytes and decreased levels of keratins 14, 5, and 15. Primary keratinocytes isolated from transgenic mice
manifest reduced proliferation and migration. Moreover, clonogenicity assessment and label-retaining analysis
reveal a reduction in keratinocyte progenitor cell number in transgenic mice. Response to IGF-1 is strongly
impaired in cultured transgenic keratinocytes compared with wild-type cells. Consistently, activation of
phosphoinositol 3-kinase (PI3K), AKT, and Rac1, all IGF-1 downstream mediators, is reduced. Our results
demonstrate that 14-3-3s controls the in vivo epidermal proliferation–differentiation switch by reducing
proliferative potential and forcing keratinocytes to exit the cell cycle, and that this effect associates with
inhibition of the IGF-1 pathway.
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INTRODUCTION
The balance between keratinocyte proliferation and differ-
entiation has a pivotal role for the maintenance of skin
homeostasis. Stem cells in the bulge of the hair follicle
and in the basal layer of interfollicular epidermis guarantee
epidermal renewal (Watt and Jensen, 2009). These cells
can enter into an active proliferating state, generating
transient amplifying cells that exit from the cell cycle,
move in the suprabasal layers, and differentiate. Several
molecular mediators control the keratinocyte proliferation/
differentiation switch (Koster and Roop, 2007; Blanpain
and Fuchs, 2009). Despite major achievements in the
understanding of such regulation over the last years, many
aspects remain to be determined.
14-3-3s, also known as stratifin, is a member of the 14-3-3
protein family specifically expressed in stratified epithelia.
Like other 14-3-3 isoforms, 14-3-3s controls diverse
biochemical processes by binding to many different ligands
via a consensus motif phosphorylated on serine or threonine
residues. A targeted proteomic analysis identified several
14-3-3s-binding partners belonging to subclasses involved in
the regulation of cytoskeletal dynamics, polarity, adhesion,
mitogenetic signaling, and motility (Benzinger et al., 2005).
Several lines of evidence suggest that 14-3-3s exerts
an important role in cell cycle progression control. First,
14-3-3s expression is positively regulated by p53 following
DNA damage, leading to a stable G2/M mitotic arrest
(Hermeking et al., 1997). Moreover, 14-3-3s expression is
silenced following promoter hypermethylation in different
carcinomas (Lodygin and Hermeking, 2006), whereas ectopic
14-3-3s expression in tumor cells leads to G2/M arrest
(Hermeking et al., 1997; Ferguson et al., 2000).
In the epidermis, 14-3-3s expression is low in the
basal compartment and highly upregulated in suprabasal
keratinocytes (Dellambra et al., 2000). Downregulation of
14-3-3s prevents senescence and leads to immortalization of
cultured keratinocytes (Dellambra et al., 2000). In vivo,
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epigenetic 14-3-3s silencing has been shown in epidermal
tumors of the basal-cell compartment (Lodygin et al., 2003).
Moreover, a mutation in 14-3-3s, resulting in a truncated
protein potentially acting as a dominant-negative, was found
in the repeated epilation mice (Herron et al., 2005; Li et al.,
2005) that show a hyperproliferative epidermis lacking a
cornified envelope and, as heterozygous, display repeated
hair loss, and a tendency to develop skin tumors (Holbrook
et al., 1982; Lutzner et al., 1985). Together, these findings
support the concept that 14-3-3s promotes keratinocyte cell
cycle withdrawal and differentiation.
In apparent contrast to this data, 14-3-3s has been found to
be highly expressed in conditions associated with keratinocyte
hyperproliferation, such as in squamous cell carcinomas and
psoriasis (Lodygin et al., 2003). Moreover, 14-3-3s expression
is increased in the upper layers of hyperproliferative epidermis
in keratin 10 (K10)-null mice (Reichelt and Magin, 2002).
These findings suggest that high 14-3-3s expression levels
may be not generally required for cell cycle withdrawal,
and point to the necessity to further investigate the role and
mechanism of action of 14-3-3s in vivo.
To analyze 14-3-3s role in epidermal homeostasis, we
generated transgenic mice overexpressing 14-3-3s under the
control of a K14 promoter (K14-s transgenic mice), which
results in high expression in basal epidermal keratinocytes
and keratinocytes of the outer root sheath in the hair follicle.
RESULTS
Overt skin phenotype of K14-r transgenic mice
Two transgenic lines overexpressing human 14-3-3s under
the control of a K14 promoter were generated. The first one
(line 7) showed patchy desquamating skin lesions early in life
(Supplementary Figure S1 online) and sparse hair loss with
age (not shown). However, because of breeding difficulties,
susceptibility to skin infections leading to poor health
conditions and short life span, only a preliminary character-
ization of this line could be performed. The other line
(line 44) only displayed early wrinkle appearance starting
from 8–10 weeks of age (Figure 1). Upon wax depilation, a
high percentage of transgenic mice from line 44 manifested
excoriated skin lesions (77.8% versus 30% in wild-type mice)
and incomplete hair regrowth (72.7%; Figure 1). Despite the
less severe phenotype, this line manifested similar features to
line 7, and thus was chosen for the phenotypic characteriza-
tion of 14-3-3s overexpression. Line 44 contained around
14 transgene copies.
In situ hybridization, immunohistochemistry, and western
blot analysis revealed a strong increase of 14-3-3s expression
in the keratinocytes of the basal layer and of the most external
layer of the hair follicle (the outer root sheath) in transgenic
mice compared with wild-type controls (Supplementary
Figure S2 online).
Reduced thickness and expression of proliferating keratinocyte
markers in the epidermis of transgenic mice
Histological analysis revealed that the epidermis of trans-
genic mice was thinner than that of wild-type controls
(Figures 2a–e). Epidermal hypoplasia started to be evident in
the skin of adult mice and became more marked with
increasing age (Figures 2c and d). A reduction in hair follicle
density was also observed (Figures 2f and g).
The decrease in epidermal thickness suggested that
14-3-3s overexpression may interfere with differentiation.
To examine this aspect, immunohistochemistry was per-
formed on newborn back skin and adult tail skin with the
following markers: K14, K15, K6, K10, involucrin, and
loricrin. No obvious alterations in expression pattern could
be detected for K10, involucrin, loricrin, K15 (Supplementary
Figure S3A online), or K6 (data not shown). However, K14
staining was strongly reduced in basal keratinocytes of
interfollicular epidermis and hair follicle outer root sheath
in transgenic mice (Figure 3a).
Western blot analysis on protein extracts from isolated
keratinocytes confirmed the strong reduction in K14 protein
levels in transgenic animals (0.19±0.08 relative amount
versus wild type). Expression levels of K5, the K14 partner in
proliferating keratinocytes, were also strongly decreased
(0.29±0.02). In addition, the level of K15, which detects
hair follicle stem cells and, in newborn mice, also basal-
proliferating keratinocytes (Liu et al., 2003), was significantly
reduced (0.47±0.11), whereas involucrin and loricrin,
markers of suprabasal differentiated keratinocytes, were
increased (1.56±0.19 and 1.80±0.27, respectively; Supple-
mentary Figure S3B online). K10 and K6 protein levels were
not different between wild-type and transgenic keratinocytes
(0.86±0.17 and 0.97±0.62, respectively; Supplementary
Figure S3B online). The expression of K14 and K5 mRNAs
was also analyzed by real-time RT-PCR and shown to be
significantly decreased in transgenic mice as compared with
wild-type ones (K14: 0.49±0.002; K5: 0.48±0.01; Figures
3c and d).
To evaluate whether apoptosis contributes to the decrease
in epidermal thickness, a TUNEL staining was performed.
In both K14-s and wild-type mice, a small and comparable
percentage of keratinocytes of the most differentiated layers
were stained (1.79%±1.05, wild-type mice; 1.96%±1.10,
transgenic mice; Supplementary Figure S4 online).
WT Tg
Day 0
Day 28
Figure 1. Overt skin phenotype of transgenic mice overexpressing 14-3-3r.
Ten-week-old transgenic mice and wild-type controls of transgenic line 44.
The only apparent difference of this line is early wrinkles in the skin of
transgenic mice as compared with controls (day 0). After wax depilation,
several excoriated skin lesions are evident (arrows, day 0) and hair regrowth is
often incomplete (day 28) in transgenic mice. Tg, transgenic; WT, wild type.
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Impaired proliferation of keratinocytes overexpressing 14-3-3r
To analyze the effect of 14-3-3s overexpression on kerati-
nocyte proliferation, BrdU nuclear labeling was examined
following a single injection into mice. A significant reduction
in BrdU-positive interfollicular basal cells was found in
transgenic mice (11.37%±2.64) compared with wild-type
littermates (17.70%±3.48; Figures 4a–c). Similarly, cultured
primary keratinocytes from transgenic mice displayed a
significant decrease in BrdU incorporation compared with
wild-type controls (Figure 4d).
Moreover, scrape wounds were mechanically made in
confluent keratinocyte cultures, and gap closure was
analyzed (Figure 4e). A reduced capacity in filling the gap
was observed in keratinocyte monolayers from transgenic
mice as compared with wild-type ones. As this capacity
depends on both proliferation and migration, and 14-3-3s
was found to interact with several proteins involved in cell
motility (Benzinger et al., 2005), keratinocyte migration
was also investigated using a Boyden chamber assay. This
revealed that keratinocytes overexpressing 14-3-3s manifest
significantly reduced motility (Figure 4f).
As 14-3-3s has been shown to potentially bind several
proteins regulating cell adhesion, the adhesiveness of
transgenic keratinocytes was evaluated by a specific in vitro
assay. Wild-type and 14-3-3s-overexpressing keratinocytes
plated on type IV collagen manifested similar adhesive
properties (Figure 4g).
Reduced keratinocyte progenitor cell number in K14-r
transgenic mice
We, then, tested whether the colony-forming capacity of
keratinocytes isolated from K14-s mice was impaired.
Colony-forming assays on primary keratinocytes showed that
the number of colonies, indicative of number of proliferating
cells, was strongly decreased in transgenic mice compared
with controls (Figures 5a and b). Average colony size was
also reduced, as the majority of colonies from transgenic
keratinocytes (75.3%) showed an area below 1mm2 after
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Figure 2. Reduced epidermal thickness and hair follicle density in transgenic mice overexpressing 14-3-3r. Tail skin of a wild-type (a) and a transgenic
(b) 8-month-old mouse. White dotted bars indicate average epidermal thickness at this age. Bars¼30 mm. Computer-assisted analysis of the epidermal thickness
in the tail skin of 3-month-old (c) and 8-month-old (d) mice and in the back skin of 3-month-old mice (e; n¼ 5). Epidermal thickness was calculated by
measuring the area (A) of 10 epidermal tracts per specimen and the length of the corresponding basal layer (L) and evaluating the A/L ratio. (f) Representative
images of the back skin of adult wild-type and transgenic mice showing the reduction in hair follicle density in mice overexpressing 14-3-3s. Bars¼300 mm.
(g) Computer-assisted analysis of hair follicle (hf) density in the back skin of 3-month-old mice (n¼ 7), reported as number of hair follicles per mm of epidermal
length (No. of hf per mm) (*Po0.05 and ***Po0.005). Tg, transgenic; WT, wild type.
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1 week of culture with respect to 35.5% of colonies from
wild-type keratinocytes (Figure 5c). These small colonies
resembled the keratinocyte paraclones, the increase of which
is a measure of in vitro stem cell depletion (Barrandon and
Green, 1987; Dellambra et al., 2000).
To analyze whether the progenitor cell number was
affected in transgenic mice, an in vivo BrdU-labeling
long-term analysis was performed by multiple injections of
BrdU in 10-day-old mice. Indeed, epidermal progenitors are
slow cycling cells and retain BrdU for a longer period than
actively proliferating cells. To assess the efficiency of BrdU
labeling, a group of mice (n¼3) was killed 2 days after the
final BrdU injection. A high and similar percentage of cells
within the basal interfollicular epidermis and hair follicle
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Figure 4. Reduced keratinocyte proliferation in keratin 14-r transgenic mice. (a, b) Immunohistochemistry for BrdU in the tail skin of adult mice.
Arrows indicate positive keratinocytes in the basal layer. Bars¼ 50 mm. (c) Morphometric analysis of BrdU-positive basal cells in the epidermis (n¼ 7).
(d) BrdU incorporation in cultured keratinocytes from newborn mice (n¼ 5). (e) Representative scratch assay images taken at 0 and 48hours after
wounding (n¼4). (f) Boyden chamber assay on cultured keratinocytes (*Po0.05; n¼ 4). (g) Adhesion assay with keratinocytes seeded at different density
(black: 5 104 cells; gray: 105 cells; and white: 2 105 cells; n¼ 4). Tg, transgenic; WT, wild type.
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Figure 3. Altered epidermal differentiation in transgenic mice overexpressing 14-3-3r. (a) Immunohistochemistry for keratin 14 (K14) in the skin of newborn
mice. Arrows indicate the interfollicular keratinocytes of the basal layer, whereas arrowheads indicate follicular keratinocytes of the outer root sheath.
Bars¼ 100 mm. (b) Western blot for K14 and K5 on protein extracts from keratinocytes isolated from the skin of newborn mice. Numbers above western
panels indicate the fold change in transgenic mice relative to wild-type controls (**Po0.01; n¼ 4). (c, d) Real-time PCR on RNA extracted from keratinocytes
freshly isolated from the skin of newborn mice. Values are expressed as mean±SD of two different experiments with three mice each (***Po0.005).
Tg, transgenic; Tub, tubulin; WT, wild type.
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outer root sheath were labeled in wild-type and transgenic
mice (interfollicular epidermis: wild type (WT) 71.38±1.04,
transgenic (Tg) 71.77±0.77; hair follicle: WT 75.88±1.64,
Tg 76.80±2.84), indicating that the multiple BrdU chases
were able to label most of proliferating cells. Forty-five
days after BrdU injection, a reduction of 430% in label-
retaining cells was observed in the interfollicular basal
layer in transgenic mice compared with wild-type controls
(Figure 5d). Similar results were obtained by counting
BrdU-positive outer root sheath keratinocytes in the hair
follicles (Figure 5e).
Response to IGF-1 is strongly reduced in keratinocytes
of K14-r transgenic mice
To identify possible 14-3-3s target pathways responsible for
the observed effects on transgenic keratinocytes, the IGF-1
signaling was analyzed. We focused on this pathway because
several findings indicate an important function for IGF-1 in
regulating epidermal proliferation, motility, and progenitor
cell behavior (Haase et al., 2003; Sadagurski et al., 2006;
Stachelscheid et al., 2008).
BrdU incorporation was measured in keratinocytes from
transgenic and wild-type mice treated or not with IGF-1. The
mitogenic response upon IGF-1 stimulation was strongly
reduced in cultured K14-s keratinocytes as compared with
control cells (83% in wild-type keratinocytes and 16% in
transgenic keratinocytes; Figure 6a).
The responsiveness to IGF-1 was further tested by treating
scratched keratinocyte monolayers and analyzing gap closure
(Figure 6b). Forty-eight hours after wounding, starved wild-
type keratinocytes treated with IGF-1 were able to colonize
the cell-free zone similarly to those cultured in complete
medium (WTþ IGF-1: 65.30% of initial wound area
±10.75 SEM and WT complete medium: 72.52%±8.71),
whereas keratinocytes from K14-s mice treated with
IGF-1 behaved similarly to starved cells (Tgþ IGF-1:
16.49%±11.72; Tg complete medium: 21.81%±6.83; Tg
starved 18.09%±9.32; and WT starved 10.22%±5.51),
indicating a striking impairment in the proliferation and
migration capacity of K14-s keratinocytes following
IGF-1 treatment.
IGF-1R signaling is impaired in transgenic mice overexpressing
14-3-3r
To examine the mechanisms by which 14-3-3s-overexpres-
sing keratinocytes show a reduced response to IGF, we first
analyzed the expression of IGF-1 receptor (IGF-1R) in
keratinocytes isolated from newborn mice. A significant
reduction in IGF-1R expression was found at the RNA
(0.39±0.05 relative amount; n¼ 4; P¼ 0.0016) and protein
level (0.55±0.18; Figure 6c) in 14-3-3s-overexpressing
keratinocytes as compared with controls.
IGF-1R stimulates phosphoinositol 3-kinase (PI3K) in
keratinocytes, thereby activating its downstream pathway
(Haase et al., 2003; Sadagurski et al., 2006). Following IGF-1
stimulation, a reduced induction in phosphorylated PI3K with
respect to total PI3K was observed in keratinocytes over-
expressing 14-3-3s (2.49±1.10-fold increase) compared
with controls (6.75±1.04-fold increase; Figure 6d).
PI3K directly phosphorylates and thus activates the
serine/threonine protein kinase Akt (Burgering and Coffer,
1995; Franke et al., 1995). Akt phosphorylation was strongly
reduced upon IGF-1 stimulation in keratinocytes from
transgenic mice compared with wild-type ones (Figure 6e).
Finally, the small GTPase Rac-1, a target of epidermal
IGF-1R signaling having an important role in the regulation of
keratinocyte proliferative potential and stemness (Stachelsc-
heid et al., 2008), was also analyzed. Following IGF treatment,
a more than 2-fold increase (2.07±0.27) in activated Rac/total
Rac was detected in wild-type keratinocytes, whereas in cells
from transgenic mice, the amount of activated Rac was
only slightly augmented (1.12±0.20; Figure 6f). Together,
these results show a strong reduction in IGF-1-mediated
signaling in 14-3-3s-expressing keratinocytes.
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Figure 5. Decreased stem cell maintenance in keratin 14-r transgenic mice. (a) Colony-forming assay performed on first passage keratinocytes of wild-type
and transgenic animals. (b) Colony-forming assay values expressed as number of colonies 100 per total cells seeded (n¼ 4). (c) Computer-assisted
analysis of colony size (n¼ 4). Values of the percentage of colonies with different diameters are: o1mm2, 35.5 WT, 75.3 Tg; 1–2mm2, 59.1 WT, 24.0 Tg;
42mm2, 5.4 WT, 0.7 Tg (d). Computer-assisted analysis of the number of interfollicular basal keratinocytes (d) and follicular keratinocytes (e) retaining BrdU
staining at 45 days after injection. Values are expressed as labeled cells 100 per total cells counted (n¼ 7). *Po0.05 and ***Po0.005.
Tg, transgenic; WT, wild type.
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DISCUSSION
To define the in vivo role of 14-3-3s in controlling epidermal
homeostasis, we generated transgenic mice that express
this protein at high levels in basal-proliferating keratinocytes.
Our analysis revealed that 14-3-3s overexpression forces
basal keratinocytes to exit the cell cycle and to differentiate
prematurely, resulting in a reduction of both epidermal
proliferative capacity and progenitor stem cell number.
The decreased proliferation potential parallels with
reduced K14 and K5 gene expression both at mRNA and
protein level. As these keratins identify highly proliferating
keratinocytes (Byrne et al., 1994), these findings indicate that
14-3-3s levels have an impact on proliferative potential of
these cells.
Our in vivo data are consistent with previously reported
in vitro findings that suggested that the downregulation of
14-3-3s is a crucial step in keratinocyte immortalization
(Dellambra et al., 2000). Our observations also agree with a
tumor suppressor function of 14-3-3s, which was shown to
be silenced in cutaneous basal cell carcinomas by promoter
hypermethylation (Lodygin et al., 2003) and mutated in the
naturally occurring tumor prone repeated epilation mouse
model (Herron et al., 2005; Li et al., 2005).
In apparent contrast to our data, high levels of 14-3-3s are
expressed in cutaneous squamous cell carcinomas
and hyperproliferative epidermis of inflammatory skin dis-
orders (Lodygin et al., 2003). One possible explanation is that
14-3-3s has additional roles in pathological conditions, such
as the prevention of apoptosis and promotion of cell survival
(Samuel et al., 2001; Oh et al., 2009). Another possibility
could be that 14-3-3s is induced under hyperproliferative
stress to counteract uncontrolled proliferation.
To assess the molecular alterations underlying the
proliferative defect and the reduced progenitor stem cell
number in transgenic mice, IGF-1R signaling pathway was
investigated. Basal keratinocytes express IGF-1R and are
thought to respond to fibroblast-released IGF-1 with an
increase in cell proliferation and migration. Stachelscheid
et al. (2008) showed that IGF-1R signaling has a central
role in the regulation of progenitor cell behavior in the
interfollicular epidermis and in promoting keratinocyte
proliferation, in part, through the small GTPase Rac-1. Our
findings clearly show that keratinocytes of transgenic mice
are less responsive to IGF-1.
A reduction in the IGF-1 signaling pathway was observed,
as the activities of PI3K, Akt, and Rac, key downstream
targets, were all blunted in 14-3-3s transgenic keratinocytes.
The 14-3-3s has been described to physically associate with
and inhibit Akt (Yang et al., 2006). In line with this finding,
we observed a strong downregulation of Akt activity. The
decrease in IGF-1R/PI3K activity is likely to be responsible for
the impaired migration observed in 14-3-3s keratinocytes,
as PI3K was shown to also regulate human keratinocyte
migration (Haase et al., 2003).
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In disagreement with our data, Zhang et al. (2004)
reported that 14-3-3s was upregulated in a breast cancer
cell line treated with IGF-1 and that the increased 14-3-3s
levels were necessary to mediate the mitogenic effect of
IGF-1. Again, this apparent discrepancy could reflect the
antiapoptotic and cell survival functions that 14-3-3s might
have in a pathological model such as tumor cells (Samuel
et al., 2001).
As 14-3-3s interacts with a great number of proteins, it is
conceivable that other molecular pathways are also respon-
sible for decreased keratinocyte proliferation and progenitor
stem cell number in transgenic mice. However, the strongly
reduced responsiveness to IGF-1 points to a relevant role of
this signaling route in determining the epidermal phenotype
of K14-s mice.
Taken together, our results provide evidence that 14-3-3s
has a crucial role in the control of the proliferation/
differentiation switch in keratinocytes and indicate that
increased 14-3-3s levels inhibit IGF-1 cell responsiveness,
leading to decreased keratinocyte proliferation and progeni-
tor cell number.
MATERIALS AND METHODS
Generation of transgenic mice
Transgene was constructed by cloning the full-length coding
sequence of the human 14-3-3s complementary DNA into a K14
cassette expression vector (Vassar et al., 1989). Transgenic mice
were generated by pronuclear injection of fertilized oocytes from a
C57Bl/6xDBA/2 mouse cross, and transgenic lines were established
on a BDF1 background. Mice were screened by tail tip DNA
PCR analysis using the following primers: forward 50-GGACTCCTAC
AAAGACAGCA-30, located in the 14-3-3s-coding sequence; reverse
50-CTCCTAGGGACTCTAGAGG-30, in the vector polyA sequence.
To quantify the number of inserted copies, mouse genomic DNA
was SacI digested and analyzed by Southern blotting.
Animal experiments were approved by the IDI-IRCCS Animal
Care and Use Committee.
Immunohistochemistry
Paraformaldehyde-fixed, paraffin-embedded skin sections were
processed, as described (Failla et al., 2000). The following
antibodies were used: anti-human 14-3-3s (PC482 Calbiochem,
Merck Chemicals, Nottingham, UK); anti-mouse K14 (MS-115-P1;
Lab Vision, Cheshire, UK); anti-mouse K5, K10, K6, involucrin, and
loricrin (respectively, PRB-160P, PRB-159P, PRB-169P, PRB-140C,
and PRB-145P; Covance, Berkeley, CA); and anti-mouse K15
(MS-1068-P1, Lab Vision). All antibodies were used at a concen-
tration of 2 mgml1.
In situ hybridization
In situ hybridization was performed, as previously described (Failla
et al., 2000). To generate the riboprobe, a complementary DNA
fragment was obtained by amplifying the transgenic vector with the
reverse primer used for genotyping mice and a forward primer
located 370 bp upstream. Complementary DNA was cloned into the
pCRII-TOPO vector (Invitrogen, Paisley, UK) and transcribed in the
presence of [35S]UTP (GE Healthcare, Milan, Italy).
Apoptosis analysis
The Fluorometric DeadEndT TUNEL System (Promega, Madison, WI)
was used on paraffin-embedded skin sections following manufac-
turer instructions. A total of 10 fields per section ( 100 magnifica-
tion) were analyzed using the Axiovision analysis system (Carl Zeiss,
Go¨ttingen, Germany) and counting the number of positive nuclei
with respect to total keratinocytes analyzed.
Cell cultures
Mouse keratinocytes were isolated from the skin of newborn mice,
as described (Hager et al., 1999), except that the epidermis
was dissociated following 0.05% DNase addition (Sigma-Aldrich,
Milan, Italy). Keratinocytes were plated on mouse type IV collagen
(BD Biosciences, Erembodegen, Belgium) and grown in Cnt-57
progenitor cell-targeted medium (CELLnTEC, Bern, Switzerland).
Western blot
Keratinocytes isolated, as described, for cell cultures were lysed in
RIPA buffer and boiled in SDS sample buffer. Samples were
separated in SDS-PAGE gels and transferred to PVDF membranes
(Millipore, Milan, Italy). Membranes were incubated with the same
antibodies used for immunohistochemistry at a concentration of
1mgml1, or with an anti-human 14-3-3s polyclonal antibody
1:8000 (PRIMM, Milan, Italy; Dellambra et al., 2000), or with
2mgml1 of an anti-mouse IGF-1R antibody (sc-712, Santa Cruz
Biotechnology, Heidelberg, Germany).
For analysis on cultured cells, subconfluent keratinocytes were
starved for 4 hours in Cnt-57 basal medium (CELLnTEC), stimulated
for 30minutes with 100 ngml1 of recombinant mouse IGF-1
(Peprotech, Rocky Hill, NJ) or with basal medium alone as control,
and protein extracts were separated by SDS-PAGE. For PI3K and Akt
detection, the following antibodies were used: anti-mouse Akt and
pAkt, (sc-8312 and sc-7985, respectively, Santa Cruz Biotech-
nology), at a concentration of 1mgml1; anti-mouse PI3K (4292,
Cell Signaling), at a concentration of 0.1 mgml1; pPI3K (sc-12929,
Santa Cruz Biotechnology), at a concentration of 1 mgml1.
Anti-actin or anti-tubulin (sc-5286 and sc-1616, respectively,
Santa Cruz Biotechnology) were used as loading control at a
concentration of 0.2mgml1. Detection was performed using the
ECL Western blotting detection reagents (GE Healthcare).
BrdU cell-labeling assays
For detecting proliferating keratinocytes in vivo, adult mice
were injected intraperitoneally with BrdU (Sigma-Aldrich) at
100mg per kg bodyweight and killed following a 24-hour chase
period. Skin samples were fixed in paraformaldehyde and embedded
in paraffin, and sections were stained with an anti-BrdU antibody
(M0744 clone Bu20a, DakoCytomation, Milan, Italy). Ten fields per
section ( 100 magnification) were analyzed counting the number
of interfollicular basal keratinocyte-positive nuclei with respect to
the total basal-cell number.
For detecting BrdU-retaining stem cells, 10-day-old mice were
injected intraperitoneally with 50mg kg1 BrdU for three consecu-
tive days. Following 45-day chase period, mice were killed and back
skin excised, fixed, and analyzed by immunohistochemistry, as
described above.
In vitro proliferation rate was determined by measuring BrdU
incorporation with an ELISA kit (Roche, Indianapolis, IN). Subconfluent
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keratinocytes were treated with 1mM BrdU for 16 hours, and BrdU
incorporation was evaluated following manufacturer’s instructions.
For BrdU incorporation following IGF-1 treatment, subconfluent
keratinocytes were starved for 16 hours in Cnt-57 basal medium, and
for the following 24 hours were (1) stimulated with 100 ngml1
of mouse recombinant IGF-1 (Peprotech), or (2) cultured in
Cnt-57 complete medium (positive control), or (3) maintained in
basal medium (negative control). Cells were treated with BrdU
for the last 16 hours of IGF-1 treatment and analyzed, as described
above.
Scratch assay
Confluent keratinocytes were washed in phosphate-buffered saline
and cell monolayers were then scratched with a P-200 tip (Labcon,
Hannover, Germany). Wounded monolayers were observed at
different time points after injury and pictures taken with a digital
camera. The residual gap between migrating keratinocytes was
measured with a computer-assisted analysis system and expressed as
percentage of the initial scratched area.
To test IGF-1 effect, confluent monolayers were starved overnight
in Cnt-57 basal medium and then (1) maintained in basal medium
(negative control), or (2) incubated with 100 ngml1 of recombinant
mouse IGF-1 (Peprotech), or (3) cultured in complete medium
(positive control).
Adhesion assay
Freshly isolated keratinocytes were seeded at different concentra-
tions (5 104, 105, or 2 105 cells per well) in a 24-multiwell
plate previously coated with 0.125mgml1 of mouse type IV
collagen. Cells were allowed to attach for 12 hours, washed twice
with phosphate-buffered saline to remove unattached ones, fixed
for 30minutes with paraformaldehyde, and stained with crystal
violet. Four random fields for each well were counted under
microscope.
Colony-forming assay
Four  104 keratinocytes were seeded in triplicate in 6-well
plates and cultured for 7 days. Cells were then fixed with 1%
paraformaldehyde for 15minutes and stained with crystal violet
(0.05% in phosphate-buffered saline) for 1 hour. The number of
colonies was counted, and colony dimension analyzed by using a
computer-assisted image analysis.
Rac activation assay
Rac activation was analyzed on cultured keratinocytes treated for
1 hour with 100 ngml1 of rmIGF-1 (Peprotech) following the
procedure described by Tunggal et al. (2005) and using an anti
Rac1 antibody (610650, Becton Dickinson, Erembodegen, Belgium)
diluted 1:1,000.
Boyden chamber assay
Keratinocyte migration was analyzed using Boyden chambers
(Neuroprobe, Gaithersburg, MD) equipped with 8-mm pore diameter
polycarbonate filters (Nuclepore, Whatman, Clifton, NJ) coated with
0.125mgml1 of murine collagen type VI (BD), as described
(Cianfarani et al., 2006). In all, 5  105 cells were suspended in
Cnt-57 keratinocyte medium and loaded into the upper compart-
ment of the Boyden chambers. Analysis was performed after
16 hours of incubation. Experiments were carried out on three
different cultures per genotype in triplicate.
Statistical analysis
Numerical differences were analyzed by using the unpaired, two-
tailed Student’s t-test. P-values o 0.05 were considered significant.
If not differently specified, values are expressed as mean±SD.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Caterina Cattani for skillful technical support. This work was
supported by the Italian Ministry of Health (Ricerca Corrente 09).
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Barrandon Y, Green H (1987) Three clonal types of keratinocytes with
different capacities for multiplication. Proc Natl Acad Sci USA
84:2302–6
Benzinger A, Muster N, Koch HB et al. (2005) Targeted proteomic analysis of
14-3-3s, a p53 effector commonly silenced in cancer. Mol Cell Proteom
4:785–95
Blanpain C, Fuchs E (2009) Epidermal homeostasis: a balancing act of stem
cells in the skin. Nat Rev Mol Cell Biol 10:207–17
Burgering BM, Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidylino-
sitol-3-OH kinase signal transduction. Nature 376:599–602
Byrne C, Tainsky M, Fuchs E (1994) Programming gene expression in
developing epidermis. Development 120:2369–83
Cianfarani F, Zambruno G, Brogelli L et al. (2006) Placenta growth factor in
diabetic wound healing: altered expression and therapeutic potential.
Am J Pathol 169:1167–82
Dellambra E, Golisano O, Bondanza S et al. (2000) Downregulation of 14-3-
3s prevents clonal evolution and leads to immortalization of primary
human keratinocytes. J Cell Biol 149:1117–29
Failla CM, Odorisio T, Cianfarani F et al. (2000) Placenta growth factor is
induced in human keratinocytes during wound healing. J Invest
Dermatol 115:388–95
Ferguson AT, Evron E, Umbricht CB et al. (2000) High frequency
of hypermethylation at the 14-3-3 sigma locus leads to gene silencing
in breast cancer. Proc Natl Acad Sci USA 97:6049–54
Franke TF, Yang SI, Chan TO et al. (1995) The protein kinase encoded by the
Akt proto-oncogene is a target of the PDGF-activated phosphatidylino-
sitol 3-kinase. Cell 81:727–36
Haase I, Evans R, Pofahl R et al. (2003) Regulation in keratinocyte shape,
migration and wound epithelialisation by IGF-1- and EGF-dependent
signalling pathways. J Cell Sci 116:3227–38
Hager B, Bickenbach JR, Fleckman P (1999) Long-term culture of murine
epidermal keratinocytes. J Invest Dermatol 112:971–6
Hermeking H, Lengauer C, Polyak K et al. (1997) 14-3-3s is a p53-regulated
inhibitor of G2/M progression. Mol Cell 1:3–11
Herron BJ, Liddell RA, Parker A et al. (2005) A mutation in stratifin is
responsible for the repeated epilation (Er) phenotype in mice. Nat Genet
37:1210–2
Holbrook KA, Dale BA, Brown KS (1982) Abnormal epidermal
keratinization in the repeated epilation mutant mouse. J Cell Biol 92:
387–97
Koster MI, Roop DR (2007) Mechanisms regulating epithelial stratification.
Annu Rev Cell Dev Biol 23:93–113
Li Q, Lu Q, Estepa G et al. (2005) Proc Natl Acad Sci USA 102:15977–82
1828 Journal of Investigative Dermatology (2011), Volume 131
F Cianfarani et al.
14-3-3s In Epidermal Homeostasis
Liu Y, Lyle S, Yang Z et al. (2003) Keratin 15 promoter targets putative
epithelial stem cells in the hair follicle bulge. J Invest Dermatol
121:963–8
Lodygin D, Yazdi AS, Sander CA et al. (2003) Analysis of 14-3-3s expression
in hyperproliferative skin diseases reveals selective loss associated with
CpG-methylation in basal cell carcinoma. Oncogene 22:5519–24
Lodygin D, Hermeking H (2006) Epigenetic silencing of 14-3-3sigma in
cancer. Semin Cancer Biol 16:214–24
Lutzner MA, Guenet JL, Breitburd F (1985) Multiple cutaneous papillomas
and carcinomas that develop spontaneously in a mouse mutant,
the repeated epilation heterozygote Er/+. J Natl Cancer Inst 75:161–6
Oh JE, Jang da H, Kim H et al. (2009) Alpha3beta1 integrin promotes
cell survival via multiple interactions between 14-3-3 isoforms and
proapoptotic proteins. Exp Cell Res 315:3187–200
Reichelt J, Magin TM (2002) Hyperproliferation, induction of c-Myc and
14-3-3s, but not cell fragility in keratin-10-null mice. J Cell Sci
115:2639–50
Sadagurski M, Yakar S, Weingarten G et al. (2006) Insulin-like growth factor 1
signaling regulates skin development and inhibits skin keratinocyte
differentiation. Mol Cell Biol 26:2675–87
Samuel T, Weber HO, Rauch P et al. (2001) The G2/M regulator 14-3-3sigma
prevents apoptosis through sequestration of Bax. J Biol Chem 276:
45201–6
Stachelscheid H, Ibrahim H, Koch L et al. (2008) Epidermal insulin/IGF-1
signaling control interfollicular morphogenesis and proliferative poten-
tial through Rac activation. EMBO J 27:2091–101
Tunggal JA, Helfrich I, Schwarz H et al. (2005) E-Cadherin is essential
for in vivo epidermal barrier function by regulating tight junctions.
EMBO J 24:1146–56
Vassar R, Rosenberg M, Ross S et al. (1989) Tissue-specific and differentiation-
specific expression of a human K14 keratin gene in transgenic mice. Proc
Natl Acad Sci USA 86:1563–7
Watt FM, Jensen KB (2009) Epidermal stem cell diversity and quiescence.
EMBO Mol Med 1:260–7
Yang H, Wen YY, Zhao R et al. (2006) DNA damage-induced protein 14-3-3s
inhibits protein kinase B/Akt activation and suppresses Akt-activated
cancer. Cancer Res 66:3096–105
Zhang Y, Karas M, Zhao H et al. (2004) 14-3-3s mediation of cell cycle
progression is p53-independent in response to insulin-like growth
factor-I receptor activation. J Biol Chem 279:34353–60
www.jidonline.org 1829
F Cianfarani et al.
14-3-3s In Epidermal Homeostasis
